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SUMMARY Malignant melanoma (MM) has increased profoundly in the past 
three-four decades in white populations worldwide. Early diagnosis is crucial 
for successful treatment. We aimed to assess the accuracy rate of diagnosing 
MM in the community by the surgeon and referring physicians. We prospec-
tively collected data on all patients with preoperatively suspected or histo-
logically proven MM, treated by a single plastic surgeon, between October 
2001 and April 2005. Data were statistically analyzed using Excel software. Of 
the 50 patients with histopathologically proven MM, 74% were referred by 
dermatologists, 16% by primary caregivers, and 10% came independently or 
were under supervision of the operating plastic surgeon. Eighty percent MM 
lesions were early-stage, under 1 mm. Forty lesions were diagnosed clinically 
as MM by the plastic surgeon prior to surgery. Dermatologists diagnosed MM 
in only 30% of cases; the other 70% were referred for removal of suspect le-
sions. Dermatologists referred most MM cases. The high number of patients 
diagnosed with early stage MM (80%) reflects the efficiency of medical care in 
our community. We conclude that the diagnosis of MM in our community is 
efficient and derives from the balanced partnership between surgeons, der-
matologists, primary caregivers, and patient awareness. 
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INTRODUCTION
Malignant melanoma (MM) has increased pro-
foundly in the past three to four decades in white 
populations worldwide, especially in “sunbelt” coun-
tries like Australia, New Zealand and Israel (1-3), and 
is apparently related to the destruction of the ozone 
layer (4). In Israel, where exposure to sun is very high, 
there has been an increase of more than 300% in MM 
during the last 40 years (5). Early diagnosis of MM is 
crucial for successful treatment because when MM is 
diagnosed in its early stages, the cure rate is extreme-
ly high with a five-year survival rate of about 96% (6). 
In our prospective study, we assessed the following: 
who referred the patients with proven MM; the pre-
operative clinical accuracy rate of diagnosing MM in 
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the community by the referring physicians; the sensi-
tivity, specificity and positive predictive value of MM 
detection by the plastic surgeon removing the MM; 
and the effectiveness of MM detection in the commu-
nity according to the percentage of superficial MM.
MATERIALS AND METHODS
Institutional Review Board approval was received 
for this study. We collected preoperative data on pa-
tients undergoing surgical removal of skin lesions, 
done by a single plastic surgeon, between October 
2001 and April 2005. Diagnosis was made by clinical 
examination alone without the use of dermatoscopy, 
which is now being used. Information collected in-
cluded the relevant epidemiological data, suspected 
diagnosis of the referring physician, the referring 
physician’s specialty and the preoperative clinical 
diagnosis of the surgeon. Depth and location were 
recorded for each histologically confirmed MM. The 
percentages of different MM depths were calculated 
according to four groups: in situ MM, thin MM up to 
1 mm in depth, intermediate MM 1 mm to 4 mm, 
and MM depth over 4 mm of invasion. The sensitiv-
ity, specificity, positive predictive value and negative 
predictive value of MM detection by the surgeon 
were also calculated. 
Data were statistically analyzed using the Excel 
program.
RESULTS
During the study period, 4200 patients had 4400 
skin lesions removed and 50 of these patients had 
histopathologically proven MM. The incidence of 
MM removed was one out of every 88 biopsies taken 
(1.1%).
The mean age of the MM group was 61.4 years. 
There were 32 males, mean age 64.4, and 18 females, 
mean age 56.3. The age difference between men and 
women was not statistically significant (P=0.08). 
The depth of invasion of the MM detected in our 
study was as follows: 25 (50%) lesions MM in situ, 15 
(30%) lesions 0-1 mm in depth, 5 (10%) lesions 1-4 
mm in depth, and 5 (10%) lesions with depths of in-
vasion greater than 4 mm. Overall, 40 (80%) patients 
had MM less than 1 mm of invasion (Table 1). 
The distribution of locations was as follows: 20 
(40%) on the back, 12 (24%) on the scalp and face, 
and 9 (18%) on the upper limbs and lower limbs each 
(Table 1). 
Dermatologists referred 37 (74%) patients, 8 (16%) 
patients were referred by their primary caregivers, 
and 5 (10%) patients either came on their own or were 
already under the supervision of the plastic surgeon 
doing the procedure (Table 1). In patients referred by 
dermatologists, MM was listed as the diagnosis in 11 
(30%) cases, with the remainder of 26 (70%) being 
referred for the removal of either a suspect nevus or 
basal cell carcinoma (BCC). Among patients referred 
by their primary care physicians, only 1 (12.5%) lesion 
had a listed diagnosis of MM, while other lesions were 
referred to as a pigmented lesion, nevus or BCC. 
Of the 50 cases of MM, the plastic surgeon preop-
eratively diagnosed MM correctly in 40 (80%) cases. 
Among the 10 lesions preoperatively misdiagnosed, 
Table 1. Characteristics of malignant melanoma 
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Table 2. Accuracy of plastic surgeon in malignant melanoma detection
No. of melanomas Melanomas
Clinical examination
 Positive for melanoma
 Negative for melanoma
40 40 Positive predictive value 0.5
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7 (70%) lesions were diagnosed as dysplastic nevi and 
all these lesions were found to be MM in situ by histol-
ogy. Another 3 (30%) lesions were clinically suspected 
to be BCC, but were found to be non-melanotic MM 
on histopathology. Among all 4400 biopsies taken, 
the plastic surgeon made the clinical diagnosis of MM 
in 80 cases and it was correct in 40 (50%) of them. The 
rest of lesions were found to be dysplastic nevi, BCC, 
hemangioma, blue nevi, seborrheic keratosis and 
lentigo simplex. The plastic surgeon sensitivity for 
detection of MM was 0.8, specificity 0.99 and positive 
predictive value 0.5 (Table 2).
DISCUSSION
In the United States, MM is the fifth most common 
malignancy in men and the sixth most common in 
women (7). It is estimated that MM will afflict approxi-
mately one in 52 men and one in 77 women in the 
United States during their lifetime (7). The incidence 
of MM in the world is increasing more rapidly than of 
other malignancies and is estimated to rise by 3% to 
8% each year (1). Local excision results in a cure rate 
that is higher than 90% for thin melanomas (Breslow 
thickness <1 mm), while metastatic disease is resis-
tant to both surgery and chemotherapy and is associ-
ated with 5-year survival rates of less than 20% (8). 
There is a global effort to: 1) prevent MM of the skin 
by restricting sun exposure; and 2) educate the public 
to seek medical advice for all suspect pigmented le-
sions to allow for early detection and increase cure 
rates.
In Israel, patients may seek consultation for skin le-
sions by approaching their primary caregiver or visiting 
directly a dermatologist without referral. Usually, the 
waiting time for surgical removal is relatively short. 
In our study, we reviewed the MM patients in 
the clinical practice of a single plastic surgeon in the 
community. Of these, 50% of the MMs were in situ 
and an additional 30% were up to 1 mm in depth, so 
that 80% of our patients were stage Ι or less and only 
a small portion of patients (20%) were in a higher 
stage. In the study by Pennie et al. (9), dermatologists 
and non dermatologists diagnosed MM in stage 0 in 
18.1% and 15.6% of the patients, respectively. In the 
study by Crocetti and Carli (10), the overall percent-
age of thin tumors (≤1 mm) was 58.7% (in 53.7% of 
males and 62.2% of females). Another study that in-
cluded over 35,000 cases of melanoma found that 
thin tumors (0-0.99 mm) comprised 66% to 68% of 
their cases (11). 
Geller et al. (12) report that in the United States, 
women have a slightly higher incidence of MM before 
age 40, while after age 40, men have a higher inci-
dence and this difference increases with age. In our 
study, 64% of MM were found in men, which is con-
sistent with the findings of Geller et al. (12), since their 
mean age at MM diagnosis was 52, while the mean 
age in our study was 61.4.  
It has been noted that primary care physicians are 
less skilled in the early diagnosis of skin cancer com-
pared with dermatologists (13-15), and that patients 
with MM detected by dermatologists had a pre-
ponderance of early stage melanoma and therefore 
higher survival rates compared with those detected 
by non dermatologists (9). Thorough physical exami-
nation by a well-trained dermatologist or plastic sur-
geon on a regular basis (at least annually) increases 
the chance of early diagnosis (16). 
Patients with suspect skin lesions may delay med-
ical examination due to the lack of knowledge, fear, 
or denial. An important reason for delayed diagnosis 
of MM is that patients often think that the lesions are 
insignificant or that they are transient and will heal 
without medical intervention (17). It has been shown 
that the major reason for the delay in the diagnosis of 
MM is patient-related (18,19). A recent study demon-
strated that earlier diagnosis of second primary cuta-
neous melanomas was the result of patient education 
and careful follow up (20). Higher socioeconomic sta-
tus goes along with early presentation of the disease 
and prolonged survival (21). 
Clinical accuracy in diagnosing MM ranges from 
47% to 97%, depending on the skills and experience 
of the examiner (16). For example, Graells et al. (22) 
found 78.02% concordance rate between the initial 
clinical diagnosis of skin lesions and histologic result 
for the dermatologist and 64.83% for the family physi-
cian. Since amelanotic melanomas are difficult for all 
practitioners to diagnose, it is important to be highly 
suspicious of every fast growing lesion (19). 
In our study, dermatologists diagnosed MM pre-
operatively in only 30% of cases. The other 70% were 
thought to be suspect lesions such as dysplastic nevi 
or BCC. It must be remembered that the dermatolo-
gists were not asked to make clinical assessment as 
to the possibility of MM in all suspect lesions they 
referred for removal, so this study does not indicate 
that they have a lower capability to diagnose malig-
nancy.
The high incidence of patients that were diag-
nosed with early stages of MM in our group reflects 
the efficiency of patient referrals to the plastic sur-
geon. In Israel, patients can see a dermatologist with-
out the need for a referral from a primary physician. 
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In addition, primary caregivers show growing aware-
ness of the disease and its treatment. A prior study 
has shown that most family physicians (85%) imme-
diately refer patients with suspect lesions to a derma-
tologist or plastic surgeon (17).
CONCLUSION
In our study, we reviewed diagnostic accuracy of a 
plastic surgeon in 50 cases of MM. Of these, 50% were 
in situ, 30% were up to 1 mm in depth, and 20% were 
at a more advanced stage. Thus 80% of cases were in 
stage Ι or less, which greatly increases the chance for 
curative surgery in these patients. We found the diagno-
sis of MM in our community setting to be efficient and 
resulting from successful partnership between the der-
matologists, primary caregivers and patient awareness.
In order to improve the rate of early diagnosis, 
patient education should explain the dangers of un-
protected sun exposure, especially at an early age. It 
should also stress the importance of self-examination 
and when indicated consultations with skin cancer 
specialists. 
Cooperation and communication between refer-
ring physicians and surgeons should be encouraged. 
It is also recommended to integrate and implement 
advanced technologies such as dermoscopy and dig-
ital dermoscopy in order to improve the accuracy of 
clinical examination.
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Learn how to sunbathe properly! Before sunbathing use Nivea cream or Nivea oil; year 1935.
(from the collection of Mr. Zlatko Puntijar)
